It is intriguing to postulate that the biology of BRD3-NUT- or NSD3-NUT-driven NC may differ somewhat from that of BRD4-NUT tumors, but there are no data to support a substantial difference in the respective molecular pathways. This evidence concerns the gene BRD4 and nevus comedonicus syndrome.